Cargando…
Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer
Targeting cancer stem cell (CSC) represents a promising therapeutic approach as it can potentially fight cancer at its root. The challenge is to identify a surface therapeutic oncotarget on CSC. Tissue factor (TF) is known as a common yet specific surface target for cancer cells and tumor neovascula...
Autores principales: | Hu, Zhiwei, Xu, Jie, Cheng, Jijun, McMichael, Elizabeth, Yu, Lianbo, Carson, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352071/ https://www.ncbi.nlm.nih.gov/pubmed/27903969 http://dx.doi.org/10.18632/oncotarget.13644 |
Ejemplares similares
-
The inflammasome: an emerging therapeutic oncotarget for cancer prevention
por: Zhiyu, Wang, et al.
Publicado: (2016) -
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010) -
AXL is an oncotarget in human colorectal cancer
por: Martinelli, Erika, et al.
Publicado: (2015) -
Invasive leader cells: metastatic oncotarget
por: Cheung, Kevin J., et al.
Publicado: (2014) -
A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy
por: Li, Zhao, et al.
Publicado: (2022)